Literature DB >> 11711446

Progress in, and future prospects for, the treatment of primary pulmonary hypertension.

M R Wilkins, J Wharton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11711446      PMCID： PMC1730019          DOI： 10.1136/heart.86.6.603

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

1.  Glutaraldehyde-polymerized bovine hemoglobin and phosphodiesterase-5 inhibition.

Authors:  Robert W Gotshall; Karyn L Hamilton; Benjamin Foreman; Martha C Tissot van Patot; David C Irwin
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

2.  Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost.

Authors:  M Emmel; B Keuth; S Schickendantz
Journal:  Heart       Date:  2004-01       Impact factor: 5.994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.